EDITORIAL
Published on 01 Feb 2023
Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer
doi 10.3389/fonc.2023.1147849
- 786 views
- 2 citations
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Angiogenesis Blockade for the Treatment of Gastrointestinal Cancer
Angiogenesis Blockade for the Treatment of Gastrointestinal Cancer
9,827
Total downloads
27k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 10 Oct 2022
Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers
doi 10.3389/fonc.2022.1021772
- 1,815 views
- 4 citations
REVIEW
Published on 23 Sep 2022
Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma
doi 10.3389/fonc.2022.993573
- 2,169 views
- 4 citations
REVIEW
Published on 17 Aug 2022
Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications
doi 10.3389/fonc.2022.957068
- 1,829 views
- 4 citations
CASE REPORT
Published on 10 Aug 2022
Case report: Long-term partial response of apatinib plus paclitaxel as second-line therapy in a patient with metastatic gastric cancer
doi 10.3389/fphar.2022.888106
- 1,365 views
- 2 citations
ORIGINAL RESEARCH
Published on 30 Jun 2022
Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4
doi 10.3389/fphar.2022.797805
- 2,129 views
- 13 citations
REVIEW
Published on 19 May 2022
Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
doi 10.3389/fonc.2022.897927
- 1,053 views
- 5 citations
ORIGINAL RESEARCH
Published on 06 Apr 2022
Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab–Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study
doi 10.3389/fonc.2022.862116
- 1,801 views
- 4 citations
ORIGINAL RESEARCH
Published on 02 Mar 2022
ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway
doi 10.3389/fonc.2022.848952
- 1,684 views
- 5 citations
ORIGINAL RESEARCH
Published on 19 Jan 2022
Predictive Effect of Systemic Immune-Inflammation Index Combined With Prognostic Nutrition Index Score on Efficacy and Prognosis of Neoadjuvant Intraperitoneal and Systemic Paclitaxel Combined With Apatinib Conversion Therapy in Gastric Cancer Patients With Positive Peritoneal Lavage Cytology: A Prospective Study
doi 10.3389/fonc.2021.791912
- 2,312 views
- 25 citations
REVIEW
Published on 10 Jan 2022
Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies
doi 10.3389/fonc.2021.789330
- 2,546 views
- 13 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 27kTopic views
- 16kArticle views
- 9,827Article downloads